EU’s drug regulator approved Novavax COVID-19 vaccine
The European Union's drug regulator recommended approval for Novavax's COVID-19 vaccine, which is 94.1% effective in Phase 3 trial, UPI has learned on Monday. The European Medicines Agency (EMA) is...